309 related articles for article (PubMed ID: 36153720)
1. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
2. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
3. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
4. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
5. Anti-BP180-type mucous membrane pemphigoid: report of two cases.
Wada M; Sato J; Shindoh M; Ujiie H; Natsuga K; Nishie W; Shimizu H; Kitagawa Y
Odontology; 2016 Jan; 104(1):114-8. PubMed ID: 25355555
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
7. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.
Leverkus M; Bhol K; Hirako Y; Pas H; Sitaru C; Baier G; Bröcker EB; Jonkman MF; Ahmed AR; Zillikens D
Br J Dermatol; 2001 Dec; 145(6):998-1004. PubMed ID: 11899157
[TBL] [Abstract][Full Text] [Related]
8. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies.
Liu W; Li H; Jin Y; Cheng L; Shi L; Gao Y; Zhou Z; Feng S; Qian H; Hashimoto T; Li X
Front Immunol; 2023; 14():1149119. PubMed ID: 36969205
[TBL] [Abstract][Full Text] [Related]
9. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
[TBL] [Abstract][Full Text] [Related]
11. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay.
Yasukochi A; Teye K; Ishii N; Hashimoto T
Acta Derm Venereol; 2016 Aug; 96(6):762-7. PubMed ID: 26984589
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
15. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid.
Murakami H; Nishioka S; Setterfield J; Bhogal BS; Black MM; Zillikens D; Yancey KB; Balding SD; Giudice GJ; Diaz LA; Nishikawa T; Kiyokawa C; Hashimoto T
J Dermatol Sci; 1998 May; 17(1):39-44. PubMed ID: 9651827
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
18. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
19. Case of pemphigoid vegetans with autoantibodies against the BP180 C-terminal domain and BP230 antigen.
Doi C; Shiraishi K; Koga H; Ishii N; Sayama K
J Dermatol; 2021 Aug; 48(8):1286-1290. PubMed ID: 34003521
[TBL] [Abstract][Full Text] [Related]
20. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
